Literature DB >> 29360088

The Adenoid Microbiome in Recurrent Acute Otitis Media and Obstructive Sleep Apnea.

Carolyn O Dirain1, Rodrigo C Silva1, William O Collins1, Patrick J Antonelli1.   

Abstract

OBJECTIVE: To compare the microbial flora of adenoids from patients with recurrent acute otitis media (AOM) and patients with obstructive sleep apnea (OSA).
MATERIALS AND METHODS: This study was prospective and controlled. Adenoids were obtained from children undergoing adenoidectomy for recurrent AOM (n=7) or OSA (n=13). Specimens were processed for total deoxyribonucleic acid (DNA) isolation. 16s DNA 454-pyrosequencing was performed on AOM (n=5) and OSA (n=5) specimens. All specimens were analyzed by real-time polymerase chain reaction for the quantification of the oral commensal bacteria, Streptococcus salivarius.
RESULTS: All adenoid specimens had evidence of microbes. Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus were among the dominant species in all samples. S. salivarius, Prevotella sp. and Terrahaemophilus aromaticivorans were more common on adenoids from OSA patients (p<0.05). Bradyrhizobium sp. was more common on adenoids from patients with recurrent AOM (p<0.05). The microbial profiles associated with recurrent AOM were different from, but overlapped with OSA. S. salivarius quantified by real-time PCR was not different between the two groups.
CONCLUSION: Microbes are present on all adenoid specimens, though the microbial profile differs between recurrent AOM and OSA. The clinical significance of these differences remains to be determined.

Entities:  

Mesh:

Year:  2017        PMID: 29360088     DOI: 10.5152/iao.2017.4203

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  7 in total

1.  Comparative Analysis of Microbiome in Nasopharynx and Middle Ear in Young Children With Acute Otitis Media.

Authors:  Qingfu Xu; Steve Gill; Lei Xu; Eduardo Gonzalez; Michael E Pichichero
Journal:  Front Genet       Date:  2019-11-19       Impact factor: 4.599

2.  Analysis of the Salivary Microbiome in Obstructive Sleep Apnea Syndrome Patients.

Authors:  Peizeng Jia; Jianyin Zou; Shankai Yin; Feng Chen; Hongliang Yi; Qian Zhang
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-12-23       Impact factor: 2.471

3.  Proteomic Study Identifies Glycolytic and Inflammation Pathways Involved in Recurrent Otitis Media.

Authors:  Blendi Ura; Fulvio Celsi; Luisa Zupin; Giorgio Arrigoni; Ilaria Battisti; Bartolomea Gaita; Domenico Leonardo Grasso; Eva Orzan; Raffaella Sagredini; Egidio Barbi; Sergio Crovella
Journal:  Int J Mol Sci       Date:  2020-12-05       Impact factor: 5.923

4.  Association between adenoid bacteriology and clinical characteristics of adenoid-related diseases in children.

Authors:  Kitirat Ungkanont; Sujeenun Jootakarn; Amornrut Leelaporn; Usa Kijsinthopchai; Archwin Tanphaichitr; Vannipa Vathanophas; Chulaluk Komoltri
Journal:  SAGE Open Med       Date:  2021-04-02

5.  Properties of Mucoid Serotype 3 Streptococcus pneumoniae From Children in China.

Authors:  Ying Yang; Chun-Zhen Hua; Chao Fang; Yong-Ping Xie; Wei Li; Yong Fu; Feng Gao; Kai-Hu Yao
Journal:  Front Cell Infect Microbiol       Date:  2021-03-24       Impact factor: 5.293

6.  Characteristics of salivary microbiota in children with obstructive sleep apnea: A prospective study with polysomnography.

Authors:  Xin Huang; Xuehui Chen; Xu Gong; Ying Xu; Zhifei Xu; Xuemei Gao
Journal:  Front Cell Infect Microbiol       Date:  2022-08-29       Impact factor: 6.073

7.  Different Associations between Tonsil Microbiome, Chronic Tonsillitis, and Intermittent Hypoxemia among Obstructive Sleep Apnea Children of Different Weight Status: A Pilot Case-Control Study.

Authors:  Hai-Hua Chuang; Jen-Fu Hsu; Li-Pang Chuang; Cheng-Hsun Chiu; Yen-Lin Huang; Hsueh-Yu Li; Ning-Hung Chen; Yu-Shu Huang; Chun-Wei Chuang; Chung-Guei Huang; Hsin-Chih Lai; Li-Ang Lee
Journal:  J Pers Med       Date:  2021-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.